vs
CARLISLE COMPANIES INC（CSL）与MAXIMUS, INC.（MMS）财务数据对比。点击上方公司名可切换其他公司
MAXIMUS, INC.的季度营收约是CARLISLE COMPANIES INC的1.3倍（$1.3B vs $1.1B），CARLISLE COMPANIES INC净利率更高（12.1% vs 7.0%，领先5.2%），CARLISLE COMPANIES INC同比增速更快（-4.0% vs -4.1%），CARLISLE COMPANIES INC自由现金流更多（$-73.0M vs $-250.7M），过去两年MAXIMUS, INC.的营收复合增速更高（-0.1% vs -14.8%）
卡莱尔公司是专业建筑产品供应商，聚焦于提升建筑能效与稳固性，面向商业建筑领域生产销售单层屋面产品、质保系统及配套配件，旗下设有卡莱尔建筑材料、卡莱尔防水技术两大业务板块，产品涵盖防潮材料、屋面防护层等多个品类。
MAXIMUS是美国一家政府服务企业，业务覆盖美国、加拿大、英国等国家，为医疗补助、联邦医疗保险、医改、就业帮扶、学生贷款服务等各类政府项目提供行政及配套服务。公司总部位于弗吉尼亚州泰森斯，现有员工3.96万名，2024财年营收达53亿美元。
CSL vs MMS — 直观对比
营收规模更大
MMS
是对方的1.3倍
$1.1B
营收增速更快
CSL
高出0.1%
-4.1%
净利率更高
CSL
高出5.2%
7.0%
自由现金流更多
CSL
多$177.7M
$-250.7M
两年增速更快
MMS
近两年复合增速
-14.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.3B |
| 净利润 | $127.7M | $93.9M |
| 毛利率 | 34.5% | 23.7% |
| 营业利润率 | 17.1% | 10.9% |
| 净利率 | 12.1% | 7.0% |
| 营收同比 | -4.0% | -4.1% |
| 净利润同比 | -10.9% | 128.0% |
| 每股收益（稀释后） | $3.10 | $1.70 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSLMMS
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $1.3B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.1B | $1.4B | ||
| Q4 24 | $1.1B | $1.4B | ||
| Q3 24 | $1.3B | $1.3B | ||
| Q2 24 | $1.5B | $1.3B |
净利润CSLMMS
| Q1 26 | $127.7M | — | ||
| Q4 25 | $127.4M | $93.9M | ||
| Q3 25 | $214.2M | $75.3M | ||
| Q2 25 | $255.8M | $106.0M | ||
| Q1 25 | $143.3M | $96.6M | ||
| Q4 24 | $162.8M | $41.2M | ||
| Q3 24 | $244.3M | $72.5M | ||
| Q2 24 | $712.4M | $89.8M |
毛利率CSLMMS
| Q1 26 | 34.5% | — | ||
| Q4 25 | 33.8% | 23.7% | ||
| Q3 25 | 36.0% | 25.3% | ||
| Q2 25 | 37.3% | 26.7% | ||
| Q1 25 | 35.2% | 24.9% | ||
| Q4 24 | 36.1% | 21.5% | ||
| Q3 24 | 38.6% | 22.9% | ||
| Q2 24 | 39.2% | 25.3% |
营业利润率CSLMMS
| Q1 26 | 17.1% | — | ||
| Q4 25 | 16.8% | 10.9% | ||
| Q3 25 | 21.8% | 9.3% | ||
| Q2 25 | 23.1% | 12.3% | ||
| Q1 25 | 16.8% | 11.2% | ||
| Q4 24 | 19.9% | 6.2% | ||
| Q3 24 | 23.7% | 8.5% | ||
| Q2 24 | 26.0% | 10.8% |
净利率CSLMMS
| Q1 26 | 12.1% | — | ||
| Q4 25 | 11.3% | 7.0% | ||
| Q3 25 | 15.9% | 5.7% | ||
| Q2 25 | 17.6% | 7.9% | ||
| Q1 25 | 13.1% | 7.1% | ||
| Q4 24 | 14.5% | 2.9% | ||
| Q3 24 | 18.3% | 5.5% | ||
| Q2 24 | 49.1% | 6.8% |
每股收益（稀释后）CSLMMS
| Q1 26 | $3.10 | — | ||
| Q4 25 | $3.06 | $1.70 | ||
| Q3 25 | $4.98 | $1.27 | ||
| Q2 25 | $5.88 | $1.86 | ||
| Q1 25 | $3.20 | $1.69 | ||
| Q4 24 | $3.76 | $0.69 | ||
| Q3 24 | $5.25 | $1.18 | ||
| Q2 24 | $14.84 | $1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $771.3M | $137.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.7B | $1.7B |
| 总资产 | — | $4.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CSLMMS
| Q1 26 | $771.3M | — | ||
| Q4 25 | $1.1B | $137.6M | ||
| Q3 25 | $1.1B | $222.4M | ||
| Q2 25 | $68.4M | $59.8M | ||
| Q1 25 | $220.2M | $108.1M | ||
| Q4 24 | $753.5M | $72.7M | ||
| Q3 24 | $1.5B | $183.1M | ||
| Q2 24 | $1.7B | $102.8M |
总债务CSLMMS
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | — | ||
| Q3 25 | $2.9B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.9B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.3B | — |
股东权益CSLMMS
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.8B | $1.7B | ||
| Q3 25 | $2.0B | $1.7B | ||
| Q2 25 | $2.1B | $1.8B | ||
| Q1 25 | $2.2B | $1.7B | ||
| Q4 24 | $2.5B | $1.6B | ||
| Q3 24 | $2.8B | $1.8B | ||
| Q2 24 | $3.0B | $1.8B |
总资产CSLMMS
| Q1 26 | — | — | ||
| Q4 25 | $6.3B | $4.2B | ||
| Q3 25 | $6.5B | $4.1B | ||
| Q2 25 | $5.5B | $4.5B | ||
| Q1 25 | $5.5B | $4.2B | ||
| Q4 24 | $5.8B | $4.1B | ||
| Q3 24 | $6.5B | $4.1B | ||
| Q2 24 | $6.7B | $4.0B |
负债/权益比CSLMMS
| Q1 26 | — | — | ||
| Q4 25 | 1.61× | — | ||
| Q3 25 | 1.45× | — | ||
| Q2 25 | 0.89× | — | ||
| Q1 25 | 0.87× | — | ||
| Q4 24 | 0.77× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.76× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-244.4M |
| 自由现金流经营现金流 - 资本支出 | $-73.0M | $-250.7M |
| 自由现金流率自由现金流/营收 | -6.9% | -18.6% |
| 资本支出强度资本支出/营收 | 2.7% | 0.5% |
| 现金转化率经营现金流/净利润 | — | -2.60× |
| 过去12个月自由现金流最近4个季度 | $924.8M | $218.5M |
8季度趋势，按日历期对齐
经营现金流CSLMMS
| Q1 26 | — | — | ||
| Q4 25 | $386.0M | $-244.4M | ||
| Q3 25 | $426.9M | $649.4M | ||
| Q2 25 | $287.1M | $-182.7M | ||
| Q1 25 | $1.8M | $42.7M | ||
| Q4 24 | $370.6M | $-80.0M | ||
| Q3 24 | $312.8M | $163.8M | ||
| Q2 24 | $183.4M | $199.3M |
自由现金流CSLMMS
| Q1 26 | $-73.0M | — | ||
| Q4 25 | $346.1M | $-250.7M | ||
| Q3 25 | $393.4M | $641.8M | ||
| Q2 25 | $258.3M | $-198.2M | ||
| Q1 25 | $-27.2M | $25.5M | ||
| Q4 24 | $334.0M | $-103.0M | ||
| Q3 24 | $293.5M | $131.9M | ||
| Q2 24 | $158.5M | $164.6M |
自由现金流率CSLMMS
| Q1 26 | -6.9% | — | ||
| Q4 25 | 30.7% | -18.6% | ||
| Q3 25 | 29.2% | 48.7% | ||
| Q2 25 | 17.8% | -14.7% | ||
| Q1 25 | -2.5% | 1.9% | ||
| Q4 24 | 29.7% | -7.3% | ||
| Q3 24 | 22.0% | 10.0% | ||
| Q2 24 | 10.9% | 12.5% |
资本支出强度CSLMMS
| Q1 26 | 2.7% | — | ||
| Q4 25 | 3.5% | 0.5% | ||
| Q3 25 | 2.5% | 0.6% | ||
| Q2 25 | 2.0% | 1.1% | ||
| Q1 25 | 2.6% | 1.3% | ||
| Q4 24 | 3.3% | 1.6% | ||
| Q3 24 | 1.4% | 2.4% | ||
| Q2 24 | 1.7% | 2.6% |
现金转化率CSLMMS
| Q1 26 | — | — | ||
| Q4 25 | 3.03× | -2.60× | ||
| Q3 25 | 1.99× | 8.63× | ||
| Q2 25 | 1.12× | -1.72× | ||
| Q1 25 | 0.01× | 0.44× | ||
| Q4 24 | 2.28× | -1.94× | ||
| Q3 24 | 1.28× | 2.26× | ||
| Q2 24 | 0.26× | 2.22× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSL
暂无分部数据
MMS
| Clinical Services | $523.7M | 39% |
| Cost Plus Contracts | $386.4M | 29% |
| Outside The United States | $143.2M | 11% |
| International Government Agencies | $141.0M | 10% |
| Technology Solutions | $74.8M | 6% |
| Employment And Other | $70.2M | 5% |
| Other Including Local Municipalities And Commercial Customers | $17.6M | 1% |
